Table 6.
Outcome Regarding Immunodeficiency
| Outcome Parameters | MID (n = 40) | SID (n = 44) | VerySID (n = 19) | P Valuea |
|---|---|---|---|---|
| Duration of viral shedding, median (IQR) | 19 (14–36) | 21 (14.5–39.5) | 31 (20–44) | .140 |
| Progression to Iower RTID, n (%) | 1 (2.5) | 2 (4.5) | 3 (15.8) | .075 |
| Hospitalization, n (%) | 14 (35) | 10 (22.7) | 16 (84.2) | <.001 |
| Admission to ICU, n (%) | 0 | 1 (2.3) | 5 (26.3) | <.001 |
| Mechanic ventilation, n (%) | 0 | 0 | 2 (10.5) | |
| Mortality, n (%) | 0 | 0 | 6 (31.6) | <.001 |
| Viral infection attributable, n (%) | 0 | 0 | 4 (21.1) |
Abbreviations: ICU, intensive care unit; ID, immunodeficiency; IQR, interquartile range; MID, moderate immunodeficiency; RTID, respiratory tract infectious disease; SID, severe immunodeficiency.
aComparisons between patients with verySID and patients with MID or SID.